Dr. Kramer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
140 Jfk Dr
Atlantis, FL 33462Phone+1 561-968-6767Fax+1 561-641-0814
Education & Training
University of Pennsylvania Health SystemResidency, Neurology, 1989 - 1990- University of Pennsylvania Health SystemResidency, Neurology, 1985 - 1988
Cooper Medical School of Rowan University/Cooper University HospitalInternship, Internal Medicine, 1984 - 1985
Lewis Katz School of Medicine at Temple UniversityClass of 1984
Certifications & Licensure
FL State Medical License 2002 - 2026
PA State Medical License 1985 - 2024
NJ State Medical License 1990 - 2003- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 19 citationsNeurologic complications in children with soft tissue and osseous sarcoma.Eric D. Kramer, Donald W. Lewis, Beverly Raney, Richard B. Womer, Roger J. Packer
Cancer. 1989-12-15 - 30 citationsStaging and Surveillance of Children with Central Nervous System Neoplasms: Recommendations of the Neurology and Tumor Imaging Committees of the Children’s Cancer GroupEric D. Kramer, L G Vezina, Roger J. Packer, Charles R. Fitz, Robert A. Zimmerman
Pediatric Neurosurgery. 1994-01-01 - 166 citationsImproved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma.Roger J. Packer, Leslie N. Sutton, Joel W. Goldwein, Giorgio Perilongo, Greta R. Bunin
Journal of Neurosurgery. 1991-03-01
Press Mentions
JEM Research Institute Seeks Participants for Sunovion’s Investigational Treatment for Parkinson’s Disease Psychosis Clinical TrialOctober 2nd, 2019
SEP361-203 Study Evaluating an Investigational Medication in People with Parkinson's Disease Experiencing Hallucinations and DelusionsOctober 1st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
